Stock futures were little changed as investors await Fed rate decision: Live updates
Wall Street is coming off a second day of fresh records for the major averages.
Wikipedia founder Jimmy Wales isn’t worried about Elon Musk’s Grokipedia: ‘Not optimistic he will create anything very useful right now’
Elon Musk launched Grokipedia to rival Wikipedia and what he says is ‘woke’ bias, but founder Jimmy Wales isn’t worried, and says LLMs can’t even write a wiki.
Stocks making the biggest moves after hours: Visa, Seagate, Caesars Entertainment, Mondelez and more
These are the stocks posting the largest moves in extended trading.
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
Shares of Cytokinetics, which targets medicines for specialty heart diseases, have jumped about 69% over the past three months and are up 31% year to date.
Santoli’s Tuesday market wrap-up: Breakout to fresh record highs comes with bifurcated, top-heavy tape
Apple and Microsoft each reaching $4 trillion in market cap on the same day is in a sense fitting — they’re tech’s two steadiest mega-compounders since 2015.
Lucid targets industry-first self-driving car technology with Nvidia
Lucid plans to be the first automaker to offer highly advanced self-driving capabilities in its vehicles in the coming years, the automaker said Tuesday.
Judge extends ban on Trump firing federal workers during government shutdown
A federal judge extended a temporary order blocking the Trump administration’s mass-layoff plans during the government shutdown, multiple news outlets reported.
This San Francisco-based satellite company’s stock has doubled in the past three months
The stock has soared more than 215% this year despite slides earlier this year.
The Fed has a rate cut plus a bunch of other things on its plate this week. Here’s what to expect
The easy part for the Federal Reserve this week will be announcing a rate cut when it wraps up its meeting Wednesday.
Eli Lilly, Nvidia partner to build supercomputer, AI factory for drug discovery and development
It’s the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it takes to bring cures to patients.